COSMOS Pharmaceutical Corporation (3349.T) JPX

Currency In JPY

AD

Valuation

Market Cap700B
Enterprise Value692.92B
P/E Ratio15.07
PEG Ratio2.28
Price/Sales Ratio0.44
Price/Book Ratio1.72
Enterprise/Revenue0.46
Enterprise/EBITDA7.42

Fiscal Year

Fiscal YearMay 31, 2025
Most Recent QuarterFebruary 28, 2026

Profitability

Profit Margin0.03
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.12

Income Statement

Revenue1.01T
Revenue/Share13,494.1
Gross Profit213.28B
EBITDA64.85B
Net Income30.98B
Diluted EPS390.85

Balance Sheet

Total Cash30.88B
Total Cash/Share389.63
Total Debt50.76B
Total Debt/Equity0.19
Current Ratio0.66
Book Value Per Share3,460.35

Price History

52-Week Change-34.66
52-Week High10,045
52-Week Low5,615
Moving Average 50 Days6,126.14
Moving Average 200 Days7,157.06

Statistics

Average Volume432,296
Shares Outstanding79.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate75
Trailing Annual Dividend Yield1.26
Payout Ratio0
Last Split Factor2:1
Last Split DateAugust 29, 2024
AD